
|Slideshows|October 28, 2016
ANA 2016: Selective Neuronal Dysfunction
Author(s)Samantha J. Peterson
Data blitz presentations at ANA 2016 featured studies on neuronal dysfunction and degeneration in ALS, Parkinson disease, transverse myelitis, & more.
Advertisement
Presentations at the ANA 2016 Selective Neuronal Dysfunction and Degeneration session included studies on neuronal loss in multiple system atrophy, deep brain stimulation in early Parkinson disease, treatment of transverse myelitis with dalfampridine, and a phase I trial of MSC therapy for ALS.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup
2
CN045 Promotes Oligodendrocyte Maturation, Modest Remyelination in Preclinical MS Study
3
FDA Clears Phase 2 Trial for Demyelinating Agent Lucid-MS in Progressive Multiple Sclerosis
4
Ractigen Completes Phase 2 Enrollment for RAG-17 in SOD1-ALS
5
















